What is King Pharmaceuticals's trading assets?

King Pharmaceuticals (KG) reported trading assets of $31.23M in Q1 2026.

What does trading assets mean?

Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.

King Pharmaceuticals KG Trading assets

Trading assets at other companies

SiriusPointSPNT

$111.3M-21.0%

Skyward Specialty Insurance Group, Inc.SKWD

$54.61M+107%

Universal Insurance HoldingsUVE

$144.78M-26.2%

Arch Capital GroupACGL

——

Reinsurance Group of AmericaRGA

——

W.R. BerkleyWRB

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's trading assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's trading assets?: King Pharmaceuticals (KG) reported trading assets of $31.23M in Q1 2026.
What does trading assets mean?: Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.